Review on recent advances in supported metal catalysts for synthesis of high energy density fuels
Li Tian,
No information about this author
Dandan Jia,
No information about this author
Shenglan Zhou
No information about this author
et al.
Fuel,
Journal Year:
2024,
Volume and Issue:
373, P. 132329 - 132329
Published: July 1, 2024
Language: Английский
Research progress in the synthesis of high-energy-density fuels
Lifu Xiong,
No information about this author
C.-Y. Wu,
No information about this author
M.L. Li
No information about this author
et al.
Fuel Processing Technology,
Journal Year:
2025,
Volume and Issue:
271, P. 108200 - 108200
Published: March 10, 2025
Language: Английский
Engineering Escherichia coli for Perillyl Alcohol Production with Reduced Endogenous Dehydrogenation
Yan‐Peng Hao,
No information about this author
Meiling Liu,
No information about this author
Eric Fordjour
No information about this author
et al.
ACS Synthetic Biology,
Journal Year:
2025,
Volume and Issue:
14(5), P. 1594 - 1605
Published: April 25, 2025
Perillyl
alcohol
is
a
widely
utilized
antitumor
agent
in
cancer
therapy.
Due
to
the
limitations
associated
with
chemical
synthesis
and
plant
extraction
methods,
bioengineering
microorganisms
for
production
of
perillyl
its
precursor
limonene
offers
more
scalable
industrially
compatible
approach.
In
this
study,
we
present
design
an
Escherichia
coli
cell
factory
capable
de
novo
from
glucose.
A
comprehensive
systems
engineering
approach
was
employed
increase
availability,
enhance
electron
transfer
efficiency,
reduce
byproduct
formation,
resulting
efficient
production.
Specifically,
ribosome-binding
site
optimization
increased
enzyme
expression
improved
417.04
mg/L.
Additionally,
overexpression
cytochrome
P450
transport
proteins,
knockdown
endogenous
ethanol
dehydrogenase
prevent
product
loss,
implementation
two-phase
fermentation
led
309.1
mg/L
shake
flask
cultures,
which
marks
highest
titer
reported
systems.
This
illustrates
critical
role
reducing
aldehyde
formation
enhancing
feasibility
coli-based
production,
providing
foundation
economical
large-scale
via
microbial
bioprocessing.
Language: Английский
Microbial Fermentation and Therapeutic Potential of p-Cymene: Insights into Biosynthesis and Antimicrobial Bioactivity
Yeonhee Pyo,
No information about this author
Yeon Ja Jung
No information about this author
Fermentation,
Journal Year:
2024,
Volume and Issue:
10(9), P. 488 - 488
Published: Sept. 19, 2024
p-Cymene
(p-C)
[1-methyl-4-(1-methylethyl)-benzene]
is
a
monoterpene
found
in
variety
of
plants
and
has
several
biological
activities,
including
antioxidant,
anti-inflammatory,
antimicrobial,
anticancer
properties.
This
paper
explores
the
microbial
fermentation
pathways
involved
biosynthesis
p-C,
with
an
emphasis
on
its
potential
as
therapeutic
agent.
Through
biochemical
processes,
p-C
can
be
produced
using
renewable
precursors
such
limonene
1,8-cineole.
Recent
advances
technology
have
enhanced
efficiency
production,
highlighting
role
various
industries.
Additionally,
this
reviews
antimicrobial
bioactivity
focusing
ability
to
inhibit
pathogens
modulate
immune
responses.
The
integration
methods
offers
sustainable
approach
producing
for
applications
perfume,
cosmetics,
food,
pharmaceutical
sectors.
Understanding
these
biosynthetic
crucial
advancing
use
bio-based
chemical
potential.
In
particular,
inhibits
expression
cytokine
signal
3
intestinal
inflammation
modulates
antioxidant
immunomodulatory
systems
protect
barrier
cells
maintain
mucus
layer.
Language: Английский